The Morning: Chronic pain, rising inflation, a better green salad

When modern medicine fails, what's next?

November 11, 2021

Good morning. When modern medicine doesn't cure chronic pain, what comes next?

Justin J Wee for The New York Times

'To give them hope'

The mysterious illnesses in the Murray family started with Polly, the mother. During her pregnancies, she suffered fevers, headaches, intense joint pain and a red streak across her face.

Doctors variously diagnosed her with scoliosis and more obscure conditions, and some told her that the problem was all inside her head. "Sometimes people subconsciously want to be sick," one said. Eventually, similar symptoms afflicted her children and husband.

Millions of people have some idea of the frustrations that the Murrays endured. About one in five Americans suffers from chronic pain, often of undiagnosed origin. Many spend years searching for answers, and doctors — even if they're more sensitive than some of the Murrays' doctors — frequently fail to find any.

One of those sufferers has been my colleague Ross Douthat, a Times Opinion columnist. In 2015, Ross began to experience episodes of searing pain that at times left him unable to sleep or function. He has just published a bracingly honest memoir, "The Deep Places," about these experiences.

Today, Ross is confident that he is a long-term sufferer of Lyme disease, despite initial test results to the contrary. In that way, he has something in common with the Murrays. Their teenage son was one of the first people diagnosed with the disease after it was discovered in 1975. The disease is named for Lyme, Conn., the town where the family moved years earlier, around the time that Polly began suffering her mysterious symptoms.

The lessons from their experiences and Ross's are relevant far beyond Lyme disease. Both point to problems in American medicine — for all its great achievements — that bedevil people with mysterious pain and illness.

A middle ground

American medicine often struggles with subtlety. It treats many conditions as binary: You have it, or you don't. It fetishizes individual research studies and dismisses broader evidence or logic. (Remember when public health officials told us not to wear masks because no study yet showed them to be effective against Covid-19?)

This overly neat drawing of lines ends up serving many people poorly. It puts too much stock in a negative Lyme disease test, for example, and assumes that the disease's symptoms cannot persist for years. It imagines that an illness is either real and can be addressed with a pill or treatment — or is strictly a psychological condition.

Reality is often messier. Scientists still do not understand many common health problems, including chronic pain, and many may remain mysterious for the remainder of our lives. In the meantime, what should a sufferer do?

Ross's answer is to look for a middle ground between research science and more creative options, and to remember that modern medicine is both marvelous and still often wrong. He writes:

What we need, I'm convinced, are more people and institutions that sustain a position somewhere in between. We need a worldview that recognizes that our establishment fails in all kinds of ways, that there's a wider range of experiences than what fits within the current academic-bureaucratic lines … and yet at the same time still accepts the core achievements of modern science.

In practical terms, he offers several pieces of advice, including: Impatience is your friend. If your doctor struggles to help you, you'll need to help yourself. Trust your own experience of your body. Experiment, experiment, experiment. (He wrote a column last year laying these out, with a focus on "long Covid" patients.)

After reading Ross's book and talking with him about it, I was reminded of how often modern medicine is both a vital part of treatment and an incomplete one. For many people, the path to a healthier, better life involves not only a doctor's treatment but also some combination of physical therapy, dietary changes, exercise, massage, acupuncture, podiatry and more.

In the future, it's even possible that medical science will come to understand why some of those measures worked better than a doctor's approach. Medicine is a changing discipline, and it always will be.

In the conclusion of "Deep Places," Ross ends on a note of optimism:

I am writing this story in part for those chronically suffering, more numerous than the healthy ever realize — to give them hope that their condition can be changed even if it can't be eliminated, that they might be able to save their own lives even if they feel abandoned by their doctors, that they might, like me, be able to get, not fully well yet, but better, genuinely better.

Related: My colleagues in the Well section examine recent changes in how people understand and treat chronic pain. "The latest science shows that there are many powerful tools available to patients to take control of the pain in their lives — and perhaps begin anew," Erik Vance writes in the introduction.


The Virus
Economy and Business
Source: U.S. Bureau of Labor Statistics
  • "Everything from a gallon of gas to a loaf of bread costs more, and it's worrisome," President Biden said. He said his infrastructure bill would help ease supply-chain issues.
  • After one day on the stock market, Rivian — an electric truck maker — is worth more than Ford.
  • The Justice Department and the S.E.C. are investigating Ozy Media, which shuttered most of its operations after a Times investigation.
Other Big Stories
Kyle Rittenhouse on the witness stand.Pool photo by Mark Hertzberg

The word "woke" became powerful. That's why it's under attack, says Charles Blow.

"The world (mostly) doesn't need new inventions. It needs better distribution of what's already out there," David Bornstein and Tina Rosenberg write in their final Fixes column.

Subscribe Today

With a subscription to The Times, you'll receive unlimited access to the journalism you've been eager to discover. In-depth reporting and exclusive events, newsletters, expert analysis and more. Subscribe today.


Mohammed Ahmed, left, and Syed Khalid Wasim are fixtures of the neighborhood.Tim Barber for The New York Times

Casa: How a West Village magazine shop became a magnet for stars.

Forensics: DNA from a tree has sent someone to prison.

Vietnam: A video of a Communist Party leader eating a gold-flecked steak has vanished.

A Times classic: Build resilience as an adult.

Lives Lived: Ruth Ann Minner rose from being a receptionist in the Delaware governor's office to becoming a two-term governor herself — and a political ally of a future president, Joe Biden. She died at 86.


Bianca Marroquín used to play Roxie Hart — now she's Velma Kelly.Jeenah Moon for The New York Times

The legacy of 'Chicago'

When "Chicago" premiered in 1975, it wasn't a hit. Inspired by sensationalist murder trials, the vaudeville-style musical follows the character Roxie Hart's ascent to fame after she kills her lover. The production "seemed too chilly, in those days, to be truly loved," Ben Brantley wrote in The Times, pointing to the show's themes of "greed, corruption, violence, exploitation, adultery and treachery."

But then came a streamlined reworking of the production in 1996 that bubbled "like vintage Champagne," Brantley wrote. "Chicago" went on to become the longest-running American musical in Broadway history, and nabbed six Tony Awards, an Oscar-winning film adaptation and over 30 international reproductions.

The show has stayed fresh with the help of glitzy cast members: singers like Patti LaBelle and Usher, movie stars like Brooke Shields and Patrick Swayze, and even reality TV personalities like NeNe Leakes. "It's not a stunt: We don't take anyone that can't fulfill the stage work," the producer Barry Weissler said. "There have been people — even important people in the music world — who couldn't cut it onstage, so didn't make it into the show."

For the 25th anniversary of the revival, Juan A. Ramírez spoke with the musical's composer, producers and actors about its history. — Sanam Yar, a Morning writer


What to Cook
Linda Xiao for The New York Times
What to Watch

"Yellowjackets," on Showtime, follows a girls' soccer team whose plane crashes.

What We Wore

Low slung, high waisted, skinny, cropped, baggy, flared — there's no consensus on jeans these days. Is denim in an identity crisis?

Late Night
Now Time to Play

The pangram from yesterday's Spelling Bee was letdown. Here is today's puzzle — or you can play online.

(The Times is now selling Spelling Bee totes, onesies and other swag.)

Here's today's Mini Crossword, and a clue: "Er … like … I'm …" (three letters).

Thanks for spending part of your morning with The Times. See you tomorrow. — David

P.S. The word "doomerism" — despair about climate change — appeared for the first time in The Times yesterday.

"The Daily" is about the public health officials in the pandemic. On "Sway," Jaron Lanier discusses the metaverse.

Claire Moses, Ian Prasad Philbrick, Tom Wright-Piersanti, Ashley Wu and Sanam Yar contributed to The Morning. You can reach the team at

Need help? Review our newsletter help page or contact us for assistance.

You received this email because you signed up for the Morning newsletter from The New York Times, or as part of your New York Times account.

To stop receiving these emails, unsubscribe or manage your email preferences.

Subscribe to The Times

Connect with us on:


Change Your EmailPrivacy PolicyContact UsCalifornia Notices

The New York Times Company. 620 Eighth Avenue New York, NY 10018


Posts les plus consultés de ce blog

Chris Ramsey can take the heat, but what would relegation for QPR mean for black managers in the Premier League?

The Five Best Apps To Help You Lose Weight This Summer

Luke from 'Gilmore Girls' is selling out and starting a coffee brand